News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
pills drug trials syringe

Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer

Leap Therapeutics and BeiGene have started dosing patients in a trial combining an anti-PD-1 antibody with the novel targeted drug DKN-01 in patients with locally advanced gastric cancer.

Read Source